David C. Habiger
At a glance: David C. Habiger is Director at Boston Scientific (BSX). Their latest SEC Form 4, filed Aug 7, 2026, reported a purchase of $100K. On file: 5 purchase lines ($408K) and 0 sale lines ($0).
Disclosed holdings: about $733K of BSX stock: 17,160 shares reported on their latest Form 4 (filed Aug 7, 2026), valued at the Nov 20, 2026 close of $42.72. This counts only BSX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Boston Scientific Corp (BSX)
Purchase track record
Below average. Based on 3 purchases with a full 90 days of price history.
David C. Habiger's InsiderPrint
14 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about 2 times a year, typically $50K a trade.
- Bump outward: a purchase (14)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Peter Francis MinanCFO, President · NVRI · 99% match
- Evan BayhDirector · FITB · 99% match
- Paul BisaroDirector · MYGN · 98% match
- Gregory L. WeaverCFO · ALT · 98% matchTheir buys since 2023: 1 of 4 beat the S&P 500
- Robert J. LipsteinDirector · QRHC · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2026
From the SEC's insider data sets: each open-market buy by David C. Habiger, matched to how the stock did over the next 90 days against the S&P 500.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 7SEC | BSXBoston Scientific CorpPast buys 0/2 beat S&P | Buy | 2,10017,160 held (+14%) | $47.59 | $100K | -10.2% |
| Aug 5SEC | BSXBoston Scientific CorpPast buys 0/2 beat S&P | Buy | 1,04214,920 held (+8%) | $48.07 | $50K | -11.1% |
| Aug 5SEC | BSXBoston Scientific CorpPast buys 0/2 beat S&P | Buy | 14015,060 held (+1%) | $48.59 | $7K | -12.1% |
| May 21SEC | BSXBoston Scientific CorpFirst buyPast buys 0/2 beat S&P | Buy | 2,20011,628 held (+23%) | $56.95 | $125K | -25.0% |
| May 21SEC | BSXBoston Scientific CorpFirst buyPast buys 0/2 beat S&P | Buy | 2,25013,878 held (+19%) | $55.92 | $126K | -23.6% |
- Buy
Director David C Habiger bought $125K of BSX at $56.95 — first open-market purchase in our records; raises the stake by 23%.
Follow David C. Habiger
Get one email when David C. Habiger files a new purchase or sale. Free.
At most one email a day about David C. Habiger, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.